Condition

Follicular Lymphoma (2)

Follicular Lymphoma Grade IIIa (2)

Follicular Lymphoma, Grade 1 (2)

Follicular Lymphoma Grade 2 (1)

Follicular Lymphoma, Grade 2 (1)

Lymphoma (1)

Marginal Zone B Cell Lymphoma (1)

Marginal Zone Lymphoma (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

Massachusetts General Hospital (1)

Memorial Sloan Kettering Cancer Center (1)

Collaborator

Fox Chase Cancer Center (1)

Pharmacyclics LLC. (1)

TG Therapeutics (1)

Intervention

ibrutinib (1)

rituximab (1)

umbralisib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

follicular lymphoma grade iiia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma, Follicular Lymphoma, Follicular Lymphoma, Grade 1 Trial in Boston (Umbralisib, Rituximab)

Recruiting

Lymphoma
+6 more

Boston, Massachusetts
+1 more

Aug 31, 2020

Follicular Lymphoma, Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2 Trial in United States (Ibrutinib)

Terminated

Follicular Lymphoma
+3 more

Ibrutinib

Basking Ridge, New Jersey
+8 more

Jun 21, 2019